Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial - Dreger, P; Döhner, H; Ritgen, M (Blood, 2010)
et al.